What is the share price of Quest Laboratories Ltd (QUESTLAB) today?
The share price of QUESTLAB as on 9th March 2026 is ₹106.95. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Quest Laboratories Ltd (QUESTLAB) share?
The past returns of Quest Laboratories Ltd (QUESTLAB) share are- Past 1 week: -6.80%
- Past 1 month: 5.89%
- Past 3 months: 24.36%
- Past 6 months: 11.41%
- Past 1 year: -7.04%
- Past 3 years: N/A%
- Past 5 years: -27.42%
What are the peers or stocks similar to Quest Laboratories Ltd (QUESTLAB)?
The peers or stocks similar to Quest Laboratories Ltd (QUESTLAB) include:What is the market cap of Quest Laboratories Ltd (QUESTLAB) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Quest Laboratories Ltd (QUESTLAB) is ₹175.26 Cr as of 9th March 2026.What is the 52 week high and low of Quest Laboratories Ltd (QUESTLAB) share?
The 52-week high of Quest Laboratories Ltd (QUESTLAB) is ₹140.35 and the 52-week low is ₹75.15.What is the PE and PB ratio of Quest Laboratories Ltd (QUESTLAB) stock?
The P/E (price-to-earnings) ratio of Quest Laboratories Ltd (QUESTLAB) is 12.93. The P/B (price-to-book) ratio is 2.14.Which sector does Quest Laboratories Ltd (QUESTLAB) belong to?
Quest Laboratories Ltd (QUESTLAB) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Quest Laboratories Ltd (QUESTLAB) shares?
You can directly buy Quest Laboratories Ltd (QUESTLAB) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Quest Laboratories Ltd
QUESTLAB Share Price
NSE₹106.952.95% (-3.25)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
QUESTLAB Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
QUESTLAB Performance & Key Metrics
QUESTLAB Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 12.46 | 2.14 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.49 | 5.76 | 0.58% |
QUESTLAB Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
QUESTLAB Company Profile
Quest Laboratories Ltd manufactures a wide range of pharmaceutical formulations, including antibiotics and OTC drugs, available in various forms such as tablets and syrups.
SUNPHARMA
PE Ratio
39.68
39.68
1Y Return
12.16%
12.16%
Buy Reco %
94.29
94.29
TORNTPHARM
PE Ratio
77.45
77.45
1Y Return
42.41%
42.41%
Buy Reco %
81.48
81.48
DRREDDY
PE Ratio
18.95
18.95
1Y Return
14.89%
14.89%
Buy Reco %
51.61
51.61
CIPLA
PE Ratio
20.30
20.30
1Y Return
9.42%
9.42%
Buy Reco %
54.84
54.84
LUPIN
PE Ratio
32.08
32.08
1Y Return
14.56%
14.56%
Buy Reco %
72.22
72.22
QUESTLAB Forecast
QUESTLAB Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
QUESTLAB
QUESTLAB
Income
Balance Sheet
Cash Flow
Quarterly Normal View
QUESTLAB Income Statement
QUESTLAB Income Statement
Quarterly Normal View
| Quarter | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 21.10 | 20.61 | 15.41 | 28.06 | 15.13 | 49.86 | 25.04 | 27.04 | 31.18 | |||||||||
Operating & Other expenses | 18.36 | 17.01 | 13.47 | 18.57 | 14.17 | 45.65 | 19.37 | 22.23 | 23.70 | |||||||||
EBITDA | 2.74 | 3.60 | 1.94 | 9.49 | 0.96 | 4.21 | 5.67 | 4.81 | 7.48 | |||||||||
| Depreciation/Amortization | 0.11 | 0.15 | 0.15 | 0.14 | 0.15 | 0.19 | 0.21 | 0.21 | 0.20 | |||||||||
| PBIT | 2.63 | 3.45 | 1.79 | 9.35 | 0.81 | 4.02 | 5.46 | 4.60 | 7.28 | |||||||||
| Interest & Other Items | 0.30 | 0.15 | 0.13 | 0.37 | 0.04 | 0.37 | 0.64 | 0.58 | 0.47 | |||||||||
| PBT | 2.33 | 3.30 | 1.66 | 8.98 | 0.77 | 3.65 | 4.82 | 4.02 | 6.81 | |||||||||
| Taxes & Other Items | 0.90 | 0.95 | 0.19 | 2.91 | 0.00 | 1.73 | 0.72 | 0.00 | 2.78 | |||||||||
| Net Income | 1.43 | 2.35 | 1.47 | 6.07 | 0.77 | 1.92 | 4.10 | 4.02 | 4.03 | |||||||||
| EPS | 1.33 | 1.96 | 0.90 | 3.70 | 0.47 | 1.18 | 2.50 | 2.45 | 2.46 |
QUESTLAB Company Updates
QUESTLAB Stock Peers
QUESTLAB Past Performance & Peer Comparison
QUESTLAB Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Quest Laboratories Ltd | 12.93 | 2.14 | — |
| Sun Pharmaceutical Industries Ltd | 39.68 | 5.98 | 0.89% |
| Torrent Pharmaceuticals Ltd | 77.45 | 19.50 | 0.73% |
| Dr Reddy's Laboratories Ltd | 18.95 | 3.16 | 0.62% |
QUESTLAB Stock Price Comparison
Compare QUESTLAB with any stock or ETFCompare QUESTLAB with any stock or ETF
QUESTLAB
QUESTLAB Holdings
QUESTLAB Shareholdings
QUESTLAB Promoter Holdings Trend
QUESTLAB Promoter Holdings Trend
QUESTLAB Institutional Holdings Trend
QUESTLAB Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
QUESTLAB Shareholding Pattern
QUESTLAB Shareholding Pattern
QUESTLAB Shareholding History
QUESTLAB Shareholding History
Foreign Institutions
smallcases containing QUESTLAB stock
smallcases containing QUESTLAB stock
Looks like this stock is not in any smallcase yet.
QUESTLAB Events
QUESTLAB Events
QUESTLAB Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
QUESTLAB has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
QUESTLAB Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
QUESTLAB has not given any dividends in last 5 years
QUESTLAB Dividends
QUESTLAB Dividends
Hmm, looks like data is unavailable here. Please come back after some timeQUESTLAB Stock News & Opinions
QUESTLAB Stock News & Opinions
Articles & Videos
Earnings
Quest Laboratories standalone net profit rises 416.67% in the December 2025 quarter
Net profit of Quest Laboratories rose 416.67% to Rs 4.03 crore in the quarter ended December 2025 as against Rs 0.78 crore during the previous quarter ended December 2024. Sales rose 106.27% to Rs 30.61 crore in the quarter ended December 2025 as against Rs 14.84 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales30.6114.84 106 OPM %22.574.51 - PBDT7.010.93 654 PBT6.810.78 773 NP4.030.78 417 Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
Quest Laboratories to announce Quarterly Result
Quest Laboratories will hold a meeting of the Board of Directors of the Company on 13 February 2026.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Quest Laboratories standalone net profit declines 33.66% in the September 2025 quarter
Net profit of Quest Laboratories declined 33.66% to Rs 4.02 crore in the quarter ended September 2025 as against Rs 6.06 crore during the previous quarter ended September 2024. Sales declined 6.39% to Rs 25.62 crore in the quarter ended September 2025 as against Rs 27.37 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales25.6227.37 -6 OPM %13.2332.15 - PBDT4.239.11 -54 PBT4.028.97 -55 NP4.026.06 -34 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Quest Laboratories to discuss results
Quest Laboratories will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Quest Laboratories schedules AGM
Quest Laboratories announced that the 27th Annual General Meeting(AGM) of the company will be held on 29 September 2025.Powered by Capital Market - Live
6 months agoCapital Market - Live
Earnings
Quest Laboratories standalone net profit rises 177.03% in the June 2025 quarter
Net profit of Quest Laboratories rose 177.03% to Rs 4.10 crore in the quarter ended June 2025 as against Rs 1.48 crore during the previous quarter ended June 2024. Sales rose 52.00% to Rs 23.18 crore in the quarter ended June 2025 as against Rs 15.25 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales23.1815.25 52 OPM %16.4811.74 - PBDT5.031.82 176 PBT4.821.67 189 NP4.101.48 177 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Quest Laboratories to hold board meeting
Quest Laboratories will hold a meeting of the Board of Directors of the Company on 24 July 2025.Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Quest Laboratories to hold board meeting
Quest Laboratories will hold a meeting of the Board of Directors of the Company on 28 May 2025.Powered by Capital Market - Live
9 months agoCapital Market - Live
Corporate
Quest Laboratories to hold board meeting
Quest Laboratories will hold a meeting of the Board of Directors of the Company on 27 January 2025.Powered by Capital Market - Live
1 year agoCapital Market - Live
Corporate
Quest Laboratories to table results
Quest Laboratories will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
1 year agoCapital Market - Live
Pledged promoter holdings is insignificant